A free-radical initiator-based carrier-free smart nanobomb for targeted synergistic therapy of hypoxic breast cancer

Tumor hypoxia still severely limits the antitumor efficiency. Herein, a free-radical initiator-based carrier-free smart nanobomb with oxygen-independent trimodal therapeutic effects for targeted therapy of hypoxic breast tumor at low dose.